134 related articles for article (PubMed ID: 19181441)
1. Overexpression of follicle-stimulating hormone receptor facilitates the development of ovarian epithelial cancer.
Zhang Z; Jia L; Feng Y; Zheng W
Cancer Lett; 2009 Jun; 278(1):56-64. PubMed ID: 19181441
[TBL] [Abstract][Full Text] [Related]
2. Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone.
Zheng W; Lu JJ; Luo F; Zheng Y; Feng Yj; Felix JC; Lauchlan SC; Pike MC
Gynecol Oncol; 2000 Jan; 76(1):80-8. PubMed ID: 10620446
[TBL] [Abstract][Full Text] [Related]
3. [Preliminary study on pathway of follicle-stimulating hormone on human epithelial ovarian cancer cell proliferation].
Sheng L; Liu DY; Shen K
Zhonghua Fu Chan Ke Za Zhi; 2003 Dec; 38(12):752-5. PubMed ID: 14728848
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems.
Wang J; Lin L; Parkash V; Schwartz PE; Lauchlan SC; Zheng W
Int J Cancer; 2003 Jan; 103(3):328-34. PubMed ID: 12471615
[TBL] [Abstract][Full Text] [Related]
5. Decreased luteinizing hormone receptor mRNA expression in human ovarian epithelial cancer.
Lu JJ; Zheng Y; Kang X; Yuan JM; Lauchlan SC; Pike MC; Zheng W
Gynecol Oncol; 2000 Nov; 79(2):158-68. PubMed ID: 11063638
[TBL] [Abstract][Full Text] [Related]
6. Poor ovarian response to gonadotropin stimulation is associated with low expression of follicle-stimulating hormone receptor in granulosa cells.
Cai J; Lou HY; Dong MY; Lu XE; Zhu YM; Gao HJ; Huang HF
Fertil Steril; 2007 Jun; 87(6):1350-6. PubMed ID: 17296182
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of follicle-stimulating hormone receptor activates oncogenic pathways in preneoplastic ovarian surface epithelial cells.
Choi JH; Choi KC; Auersperg N; Leung PC
J Clin Endocrinol Metab; 2004 Nov; 89(11):5508-16. PubMed ID: 15531506
[TBL] [Abstract][Full Text] [Related]
8. Transgenic mutant D567G but not wild-type human FSH receptor overexpression provides FSH-independent and promiscuous glycoprotein hormone Sertoli cell signaling.
Allan CM; Lim P; Robson M; Spaliviero J; Handelsman DJ
Am J Physiol Endocrinol Metab; 2009 May; 296(5):E1022-8. PubMed ID: 19293333
[TBL] [Abstract][Full Text] [Related]
9. Expression and function of HOXA genes in normal and neoplastic ovarian epithelial cells.
Ota T; Klausen C; Salamanca MC; Woo HL; Leung PC; Auersperg N
Differentiation; 2009 Feb; 77(2):162-71. PubMed ID: 19281776
[TBL] [Abstract][Full Text] [Related]
10. Suppression of invasive characteristics by antisense introduction of overexpressed HOX genes in ovarian cancer cells.
Yamashita T; Tazawa S; Yawei Z; Katayama H; Kato Y; Nishiwaki K; Yokohama Y; Ishikawa M
Int J Oncol; 2006 Apr; 28(4):931-8. PubMed ID: 16525643
[TBL] [Abstract][Full Text] [Related]
11. No activating mutations of FSH receptor in four children with ovarian juvenile granulosa cell tumors and the association of these tumors with central precocious puberty.
Bas F; Pescovitz OH; Steinmetz R
J Pediatr Adolesc Gynecol; 2009 Jun; 22(3):173-9. PubMed ID: 19539204
[TBL] [Abstract][Full Text] [Related]
12. Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility.
Yang CQ; Chan KY; Ngan HY; Khoo US; Chiu PM; Chan QK; Xue WC; Cheung AN
Carcinogenesis; 2006 Jul; 27(7):1502-6. PubMed ID: 16574671
[TBL] [Abstract][Full Text] [Related]
13. Follicle stimulating hormone receptor (FSHR) antagonist and epithelial ovarian cancer (EOC).
Bose CK
J Exp Ther Oncol; 2007; 6(3):201-4. PubMed ID: 17552360
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of follicle stimulating hormone receptor (FSHR) gene in the Indian river buffalo (Bubalus bubalis).
Minj A; Mondal S; Tiwari AK; Sharma B; Varshney VP
Gen Comp Endocrinol; 2008 Sep; 158(2):147-53. PubMed ID: 18675816
[TBL] [Abstract][Full Text] [Related]
15. Expression profile of heptahelical putative membrane progesterone receptors in epithelial ovarian tumors.
Romero-Sánchez M; Peiper SC; Evans B; Wang Z; Catasús L; Ribe A; Prat J; Giri JG
Hum Pathol; 2008 Jul; 39(7):1026-33. PubMed ID: 18479732
[TBL] [Abstract][Full Text] [Related]
16. VEGF expression and enhanced production by gonadotropins in ovarian epithelial tumors.
Wang J; Luo F; Lu JJ; Chen PK; Liu P; Zheng W
Int J Cancer; 2002 Jan; 97(2):163-7. PubMed ID: 11774259
[TBL] [Abstract][Full Text] [Related]
17. Antisense oligodeoxynucleotide inhibits expression of recombinant porcine follicle-stimulating hormone receptor.
Zhu C; Wang Y; Nixon MD; La Barbera AR
Mol Reprod Dev; 2003 Jun; 65(2):188-93. PubMed ID: 12704730
[TBL] [Abstract][Full Text] [Related]
18. Toward gene therapy of primary ovarian failure: adenovirus expressing human FSH receptor corrects the Finnish C566T mutation.
Ghadami M; Salama SA; Khatoon N; Chilvers R; Nagamani M; Chedrese PJ; Al-Hendy A
Mol Hum Reprod; 2008 Jan; 14(1):9-15. PubMed ID: 18084009
[TBL] [Abstract][Full Text] [Related]
19. Seasonal relationships between dopamine D1 and D2 receptor and equine FSH receptor mRNA in equine ovarian epithelium.
King SS; Jones KL; Mullenix BA; Heath DT
Anim Reprod Sci; 2008 Oct; 108(1-2):259-66. PubMed ID: 17935915
[TBL] [Abstract][Full Text] [Related]
20. Inhibin A inhibits follicle-stimulating hormone (FSH) action by suppressing its receptor expression in cultured rat granulosa cells.
Lu C; Yang W; Chen M; Liu T; Yang J; Tan P; Li L; Hu X; Fan C; Hu Z; Liu Y
Mol Cell Endocrinol; 2009 Jan; 298(1-2):48-56. PubMed ID: 18992787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
